Gestational Diabetes — Setting Limits, Exploring Treatments

Authors:
  • JEJeffrey L. Ecker
    Jeffrey L. Ecker
  • MGMichael F. Greene
    Michael F. Greene

Abstract
Pregnancy is associated with relative carbohydrate intolerance and insulin resistance. Gestational diabetes mellitus (carbohydrate intolerance first diagnosed during pregnancy) has long been recognized as a risk factor for a number of adverse outcomes during pregnancy, including excessive fetal growth, an increased incidence of birth trauma and cesarean delivery, and neonatal metabolic abnormalities such as polycythemia, hyperbilirubinemia, and hypoglycemia.1 This recognition has led to recommendations to screen all pregnant women for gestational diabetes mellitus and to treat those whose glucose-tolerance tests exceed threshold criteria.2 The threshold criteria for diagnosing gestational diabetes were initially specified rather arbitrarily as values greater than 2 . . .